Overview

Perioperative Insulin Glargine Dosing Study

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The main objective of this study is to compare three strategies of evening insulin glargine dosing to preoperative glucose values in patients with diabetes undergoing surgery to determine which dosing strategies most often achieves the admission target study values of 100-179 mg/dl.
Phase:
Phase 4
Details
Lead Sponsor:
Tamra Dukatz
Collaborator:
Sanofi
Treatments:
Insulin
Insulin Glargine
Insulin, Globin Zinc
Insulin, Short-Acting